Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Prepaid Assets (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Prepaid Assets for 13 consecutive years, with $7.6 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 76.85% to $7.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Dec 2025, up 76.85% year-over-year, with the annual reading at $7.6 million for FY2025, 76.85% up from the prior year.
  • Prepaid Assets for Q4 2025 was $7.6 million at Theravance Biopharma, up from $6.8 million in the prior quarter.
  • The five-year high for Prepaid Assets was $12.4 million in Q2 2021, with the low at $4.1 million in Q1 2025.
  • Average Prepaid Assets over 5 years is $7.6 million, with a median of $7.6 million recorded in 2024.
  • The sharpest move saw Prepaid Assets surged 82.79% in 2021, then crashed 63.14% in 2024.
  • Over 5 years, Prepaid Assets stood at $8.6 million in 2021, then fell by 10.27% to $7.7 million in 2022, then skyrocketed by 51.04% to $11.6 million in 2023, then plummeted by 63.14% to $4.3 million in 2024, then surged by 76.85% to $7.6 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $7.6 million, $6.8 million, and $5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.